Fuchs, F., Schillinger, D., Atreya, R., Hirschmann, S., Fischer, S., Neufert, C., . . . Zundler, S. (2017). Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).
Chicago-Zitierstil (17. Ausg.)Fuchs, Friederike, Daniela Schillinger, Raja Atreya, Simon Hirschmann, Sarah Fischer, Clemens Neufert, Imke Atreya, Markus F. Neurath, und Sebastian Zundler. Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles. Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2017.
MLA-Zitierstil (9. Ausg.)Fuchs, Friederike, et al. Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2017.